Morbidity and Mortality Weekly Report (MMWR) October 4, 2019 / 68(39);851–854
2nd edition. A Guide to Managing Medicines for All Health Workers. Available for purchase via following link https://www.twn.my/title2/books/HAI.htm
Where there are no trained pharmacists serving communities, other categories of health workers are called upon to order, buy, store, dispense and ad...vise people on rational use of medicines. Where There Are No Pharmacists explains how to order them, store them, prepare them, dispense them and use them safely and effectively - it is about managing medicines. Information to help communities benefit from the use of medicines is also included.
This book walks readers through each step, covering topics ranging from policy issues to patient education. It provides guidance for anyone who is doing the work of a pharmacist; anyone who sells, dispenses, prepares, manages, or explains to others how to use medicines.
more
Source: 1,981 listener groups, engaging 9,281 individuals, conducted by IOM,
Bangladesh Betar and ACF from August to November 2018. This feedback was
collected from camps 1, 2, 10, 11, 15, 16, 19, 22, 23, 24 and 25. Listener groups included
an even spread of men, women, adults and children and ar...ound 10% of participants
were particularly vulnerable (pregnant women, lactating mothers, older people and
people with disabilities). In addition, focus group discussions were conducted in camp
24 to explore these issues in more depth.
more
Policy Brief.
WHO recommends that pregnant women receive testing for HIV, syphilis and hepatitis B (HBSAg) at least once during pregnancy, preferably in the first trimester.
Dual HIV/syphilis rapid diagnostic tests (RDTs) can be used as the first test for pregnant women as part of antenatal care (...ANC).
These simple tests can be used at the point-of-care and are cost-saving compared to standard testing in ANC. They enable more women to be diagnosed with HIV and syphilis so that they can access treatment and prevent transmission to their children.
more
This document aims to provide advice on the detection and management of ill travellers suspected of COVID-19 infection, at international airports, ports and ground crossings. It includes the following measures; 1)Detection of ill travellers; 2) Interview of ill travellers for COVID-19; 3) Reporting ...of alerts of ill travellers with suspected COVID-19 infection and 4) Isolation, initial case management and referral of ill travellers with suspected COVID-19 infection.
more
Accessed: 08.03.2020
This section provides an overview of an HIV Rapid Testing workshop. It contains information about:
- Workshop Goal
- Training Modules: Learning Objectives and Content Outline
- Learning Methods / Activities
- Recommended Certification Criteria
Section 1...: Overview, Trainer’s Guide
more
24 ФЕВРАЛЯ 2020
г. // ПРЕДВАРИТЕЛЬНАЯ РЕДАКЦИЯ
В системе здравоохранения больницы играют важнейшую роль в обеспечении населения основной медицинской помощью, особе...нно в кризисных ситуациях. Продолжительные и сочетанные вспышки могут приводить к прогрессирующему распространению заболеваний и быстрому увеличению потребностей в медицинском обслуживании, спрос на которое может превысить возможности и отдельных больниц, и системы здравоохранения в целом.
more
On the 31st December 2019, the World Health Organization (WHO) China country office reported a cluster of pneumonia cases in Wuhan City, Hubei Province of China now known to be caused by a novel virus. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been confirmed as the causative v...irus of Coronavirus disease 2019 (COVID-19). Cases have now been identified in over 100 countries including South Africa.
more
Outline
• Welcome and objectives
• Microbiology, epidemiology and clinical presentation
• Surveillance for imported cases including case definitions
• Laboratory diagnosis • Infection prevention and hospital readiness
• Patient flow and actions required at each step
• Co-ord...inating a public health response
more
Lancet Respir Med 2020Published OnlineMarch 20, 2020https://doi.org/10.1016/S2213-2600(20)30121-1
Interim Guidance 18th March 2020
COVID-19, a disease caused by a novel corona virus (SARS CoV-2), is currently a pandemic, which produces high morbidity in the elderly and in patients with associated comorbidities. Chronic kidney disease stage-5 (CKD-5) patients on dialysis [maintenance hemodialysis (MHD)or continuous ambulatory pe...ritoneal dialysis (CAPD)] are also vulnerable group because of their existing comorbidities, repeated unavoidable exposure to hospital environment and immunosuppressed state due to CKD-5. These patients are therefore not only more prone to acquire infection but also develop severe diseases as compared to general population.
more
Временные рекомендации23апреля 2020г.
This technical note contains indicators and minimum standards necessary for emergency response in the following topics: quantity of water, access to water, quality of water, sanitation, hygiene, solid waste, cleaning and disinfection, as well as dosages for the preparation of solutions disinfectants... using sodium hypochlorite.
more
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans.
METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review.
CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published.
more
Laboratory Biossafety Manual